Abstract:
Objective This work aimed to investigate the influence of polymorphisms in thymidylate synthase gene(TYMS) on toxicities related to high dose methotrexate(HD-MTX) in children with acute lymphoblastic leukemia(ALL).
Methods Direct sequencing was conducted to confirm the 3'-untranslated region(3'-UTR) polymorphisms(rs699517, rs2790, and rs11280056) in TYMS of 75 ALL children and 83 healthy subjects(controls).Clinical manifestations of 52 ALL children treated with HD-MTX, including general state of health, mucocutaneous damage, myelo-suppression, blood and urine routine examinations, hepatic and renal functions, ECG, myocardial enzymes, and so on, were evaluated retrospectively.Then, the effects of TYMS polymorphisms on toxicities of HD-MTX were investigated.
Results Compared with the TYMS rs2790 AA genotype, the number of boys carrying allele G was approximately three times that of girls(OR=3.05, 95% CI=1.14-8.19, P=0.024).TheTYMS rs2790 genotypes were related with the risk of neutropenia.The genotype GG played a protective role that reduced the risk of neutropenia(OR=0.07, 95%CI=0.01-0.64, P=0.026).TYMS rs699517 and rs11280056 were not correlated with toxicities related to HD-MTX(P > 0.05).
Conclusion TYMS rs2790 may probably be associated with HD-MTX toxicity in children ALL patients, especially boys.